Lilly del Caribe, Inc.

Form 483 issued February 17, 2023 · Carolina, Puerto Rico

Inspection
Feb 8 – Feb 17, 2023
Observations
2
Pages
4
FEI number
3004525072

In short: On February 17, 2023, FDA issued a Form 483 with 2 observations to Lilly del Caribe, Inc. in Carolina, Puerto Rico (FEI 3004525072) after an inspection that ran Feb 8 – Feb 17, 2023. The investigators were Angelica M. Hernandez, Jose Velez and Marian E. Ramirez. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

2 of 2 observations on this 483 concern quality system.

Quality system2

Most cited: 21 CFR 211.192 (1×) · 211.22 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The quality unit failed to thoroughly review any unexplained discrepancy whether or not the drug substance…

  2. 02

    The quality unit(s) should review and approve all appropriate batch records…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lilly del Caribe, Inc.?

FDA listed 2 observations on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Lilly del Caribe, Inc.?

Angelica M. Hernandez, Jose Velez and Marian E. Ramirez are named on this Form 483, for the inspection of Feb 8 – Feb 17, 2023. Each investigator has a profile showing what they cite most.

When was Lilly del Caribe, Inc. inspected by FDA?

The inspection ran Feb 8 – Feb 17, 2023, and the Form 483 is dated February 17, 2023.

How do I get the full Form 483 for Lilly del Caribe, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free